Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer

British Journal of Cancer

Volumn 88, Issue 8, 2003, Pages 1301-1309

  Bauernhofer, T ^a   Kuss, I ^a   Friebe Hoffmann, U ^a   Baum, A S ^a,c   Dworacki, G ^a   Vonderhaar, B K ^b   Whiteside, T L ^a,c  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Annexin V; Apoptosis; Fas; Prolactin; Prolactin receptor

Indexed keywords

FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 2 RECEPTOR; LIPOCORTIN 5; PROLACTIN RECEPTOR;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CANCER; CELL PROTECTION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE;

AGED; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; BREAST NEOPLASMS; FEMALE; FETAL BLOOD; HUMANS; JURKAT CELLS; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, INTERLEUKIN-2; RECEPTORS, PROLACTIN; REFERENCE VALUES; T-LYMPHOCYTES;

EID: 0038147039     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600860     Document Type: Article

References (36)

1. Badley AD, Dockrell DH, Algeciras A, Ziesmer S, Landay A, Lederman MM, Connick E, Kessler H, Kuritzkes D, Lynch DH, Roche P, Yagita H, Paya CV (1998) In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest 102: 79-87
2. Banerjee R, Ginsburg E, Vonderhaar BK (1993) Characterization of a monoclonal antibody against human prolactin receptors. Int J Cancer 55: 712-721
3. Bazan JF (1989) A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem Biophys Res Commun 164: 788-795
4. Bole Feysot C, Goffin V, Edery M, Binart N, Kelly PA (1998) Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocrin Rev 19: 225-268
5. Chen WY, Ramamoorthy P, Chen N, Sticca R, Wagner TE (1999) A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis. Clin Cancer Res 5: 3583-3593
6. Chen X, Woiciechowsky A, Raffegerst S, Schendel D, Kolb HJ, Roskrow M (2000) Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis. Br J Haematol 111: 817-825
7. Clevenger CV, Freier DO, Kline JB (1998) Prolactin receptor signal transduction in cells of the immune system. J Endocrinol 157: 187-197
8. Clevenger CV, Russell DH, Appasamy PM, Prystowsky MB (1990) Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin. Proc Natl Acad Sci USA 87: 6460-6464
9. Dardenne M, de-Moraes MdoC, Kelly PA Gagnerault MC (1994) Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry. Endocrinology 134: 2108-2114
10. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13: 795-808
11. DeMarinis L, Mancini A, Izzi D, Bianchi A, Giampietro A, Fusco A, Liberale I, Rossi S, Valle D (2000) Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer. Clin Endocrinol (Oxford) 52: 681-685
12. Dworacki G, Meidenbauer N, Kuss I, Hoffmann TK, Gooding W, Lotze M, Whiteside TL (2001) Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma. Clin Cancer Res 7: 947s-957s
13. Gala RR, Shevach EM (1993) Influence of prolactin and growth hormone on the activation of dwarf mouse lymphocytes in vivo. Proc Soc Exp Biol Med 204: 224-230
14. Hansson M, Hermodsson S, Brune M, Mellqvist UH, Naredi P, Betten A, Gehlsen KR, Hellstrand K (1999) Histamine protects T cells and natural killer cells against oxidative stress. J Interferon Cytokine Res 19: 1135-1144
15. Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL (2002) Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin. Cancer Res 8: 553-562
16. Ju ST, Panka DJ, Cui H, Ettinger R, el Khatib M, Sherr DH, Stanger BZ, Marshak Rothstein A (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444-448
17. Kiessling R, Wasserman K, Horiguchi S, Kono K, Sjoberg J, Pisa P, Petersson M (1999) Tumor-induced immune dysfunction. Cancer Immunol Immunother 48: 353-362
18. Kuss I, Saito T, Johnson JT, Whiteside TL (1999) Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin Cancer Res 5: 329-334
19. LaVoie HA, Witorsch R-J (1995) Investigation of intracellular signals mediating the anti-apoptotic action of prolactin in Nb2 lymphoma cells. Proc Soc Exp Biol Med 209: 257-269
20. Matera L (1996) Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci 59: 599-614
21. Matera L, Cesano A, Bellone G, Oberholtzer E (1992) Modulatory effect of prolactin on the resting and mitogen-induced activity of T, B, and NK lymphocytes. Brain Behav Immun 6: 409-417
22. Matera L, Cutufia M, Geuna M, Contarini M, Buttiglieri S, Galin S, Fazzari A, Cavaliere C (1997) Prolactin is an outocrine growth factor for the Jurkat human T-leukemic cell line. J Neuroimmunol 79: 12-21
23. Montgomery DW, Zukoski CF, Shah GN, Buckley AR, Pacholczyk T, Russell DH (1987) Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immunoreactivity. Biochem Biophys Res Commun 145: 692-698
24. Mukherjee P, Mastro AM, Hymer WC (1990) Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology 126(1): 88-94
25. Muschen M, Moers C, Warskulat U, Even J, Niederacher D, Beckmann MW (2000) CD95 ligand expression as a mechanism of immune escape in breast cancer. Immunology 99: 69-77
26. O'Neal KD, Schwarz LA, Yu Lee, LY (1991) Prolactin receptor gene expression in lymphoid cells. Mol Cell Endocrinol 82: 127-135
27. Peter ME, Kischkel FC, Scheuerpflug CG, Medema JP, Debatin KM, Krammer PH (1997) Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur J Immunol 27: 1207-1212
28. Saito T, Dworacki G, Gooding W, Lotze MT, Whiteside TL (2000) Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma. Clin Cancer Res 6: 1351-1364
29. Schmielau J, Finn OJ (2001) Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res. 61: 4756-4760
30. Srivastava RK (2001) TRAIL/Apo-2L: mechanisms and clinical applications in cancer. Neoplasia 3: 535-546
31. Taylor DD, Bender DP, el-Taylor GEI, Stanson J, Whiteside TL (2001) Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients. Br J Cancer 84: 1624-1629
32. Van Parijs L, Biuckians A, Ibragimov A, Alt FW, Willerford DM, Abbas AK (1997) Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor. J Immunol 158: 3738-3745
33. Weimann E, Baixeras E, Zamzami N, Kelly P (1999) Prolactin blocks glucocorticoid induced cell death by inhibiting the disruption of the mitochondrial membrane. Leuk Res 23: 751-762
34. Whiteside TL (2001) Immunobiology and immunotherapy of head and neck cancer. Curr Oncol Rep 3: 46-55
35. Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH (2001) Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 61: 4766-4772
36. Yu Lee LY (1990) Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells. Mol Cell Endocrinol 68: 21-28